1 (Image 1)
Fidaxomicin Tablet, Film Coated
Product Images NDC 0480-2596
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fidaxomicin (NDC 0480-2596). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
New (Image 2)
This text provides information about Fidaxomicin tablets with NDC 0480-2596-34. Each film-coated tablet contains 200 mg of the active ingredient. The usual dosage information can be found in the package insert. The tablets should be stored at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F). It is important to store the tablets in the original bottle and out of the reach of children. The product is manufactured for Teva Pharmaceuticals with an expiration date of 5/2024.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
